Dykema (Cannabis Law Blog)

APRIL 20, 2023

The state of Texas has a long history of regulating cannabis use. Since 1915, when the first city ordinance was passed banning cannabis in El Paso, [i] the legal landscape in Texas and the rest of the country continues to evolve at different rates. Specifically, H.B.

Law 74

Law Chronic Pain Conditions Medicine 74

Cannabis Law Report

FEBRUARY 21, 2023

Beckley Psytech plans to initiate a global multi-site Phase IIb study in H1 2023 to assess the efficacy, safety and tolerability of different doses of BPL-003 in patients with Treatment Resistant Depression […]

Safety 52

Safety Treatment Patients 52

Veriheal

NOVEMBER 28, 2023

However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests when it comes to detecting impairment induced by tetrahydrocannabinol (THC). The inaccuracy of impairment detection not only puts road safety at risk but also exposes innocent drivers to potential legal consequences.

THC 105

THC Safety Treatment Legalization 105

Cannabis Law Report

MAY 16, 2022

Gavin Newsom introduced proposed revisions to his 2022-2023 budget proposal, which would eliminate the cannabis cultivation tax rate beginning July 1, 2022. The 15% excise tax on cannabis sales would remain, and the collection and remittance of that tax would be limited to retail sales beginning January 1, 2023.

Legalization 52

Legalization Collective Education Cultivation 52

The Blunt Truth

AUGUST 22, 2022

The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C. rejecting job applicants or terminating employees) for off-duty cannabis use.

Safety 111

Safety Environment Policy Recreational 111

The Blunt Truth

JULY 5, 2023

Since 2014, Minnesota has provided applicants and employees with protections if they lawfully use cannabis for medicinal purposes. The new law amends the state’s Consumable Products Act to protect off-duty cannabis use. The new law amends the state’s Consumable Products Act to protect off-duty cannabis use.

Law 52

Law Recreational Policy Treatment 52

Veriheal

AUGUST 16, 2023

In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.

CBD 88

CBD Research and Development Treatment Policy 88

Veriheal

MARCH 31, 2023

A new study assessed whether cannabis can help those with Tourettes, Oregon and Maryland are making progress on psychedelic reform, and Idaho is getting a chance to legalize medical cannabis. The patients were given daily doses of a cannabis product with 123 milligrams of THC and 50.5 Let’s dive into this week’s cannanews.

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Medicinal Genomics

JULY 18, 2023

While there have been no documented fatal overdoses from cannabis in the 39 states that have legalized its use, there have been more than two dozen documented cases of cannabis users acquiring aspergillosis from cannabis products contaminated with Aspergillus spores. Do all cannabis products pose this risk?

Medicine 81

Medicine Patients Cannabis Therapy 81

Cannabis Law Report

SEPTEMBER 23, 2022

The continued criminalization of all drugs and the people who use them increases harms to public health and safety. Senator Wiener will look to re-enter both the overdose prevention and a revised psychedelic decriminalization bill next session.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

JULY 21, 2022

Although currently unfunded, the Cannabis Employment Protections Amendment Act of 2022 will prohibit employers from taking adverse action against employees or applicants based on their use of cannabis, their status as a medical cannabis program patient, or their failed marijuana drug test without additional indicia of impairment.

Recreational 52

Recreational Safety Programs Patients 52

Cannabis Law Report

AUGUST 23, 2022

The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C. rejecting job applicants or terminating employees) for off-duty cannabis use.

Safety 52

Safety Environment Policy Recreational 52

Medicinal Genomics

AUGUST 8, 2023

While there have been no documented fatal overdoses from cannabis in the 39 states that have legalized its use, there have been more than two dozen documented cases of cannabis users acquiring aspergillosis from cannabis products contaminated with Aspergillus spores. Do all cannabis products pose this risk?

Medicine 52

Medicine Patients Cannabis Therapy 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Medicinal Genomics

JULY 18, 2023

While there have been no documented fatal overdoses from cannabis in the 39 states that have legalized its use, there have been more than two dozen documented cases of cannabis users acquiring aspergillosis from cannabis products contaminated with Aspergillus spores. Do all cannabis products pose this risk?

Medicine 52

Medicine Patients Cannabis Therapy 52

Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. The field of psychedelic science is moving forward at a rapid pace.

Access 52

Access Therapy Clinical Trials Treatment 52

The Blunt Truth

DECEMBER 19, 2023

03-21-00571-CV, 2023 BL 341460, 2023 TX App Lexis 7448. The decision allows cannabis companies to continue selling delta-8 THC goods in Texas and establish a reputation for their brands. compounds) in the cannabis plant. The Farm Bill defines hemp as “the plant Cannabis sativa L. Dep’t of State Health Servs.

Hemp 52

Hemp Concentrates THC Marijuana 52

Veriheal

JUNE 1, 2023

It had passed through the Senate and the Public Safety and Health committees, but the Assembly Appropriations Committee gutted its main provisions. Thus, Weiner pulled it out from consideration until 2023. voters are in favor of legal access to psychedelics treatment. because there is no public hearing.”

Legalization 76

Legalization Decriminalization Legislation Therapy 76

Medicinal Genomics

JANUARY 10, 2024

Since then, CannMed has transformed into an industry event that attracts the brightest minds in cannabis science, medicine, cultivation, and safety testing. In 2023, CannMed transformed into an Innovation and Investment Summit held at the J.W. Marriott Marco Island Beach Resort, Marco Island, FL.

Research and Development 52

Research and Development Events Education Medicine 52

Veriheal

MARCH 1, 2022

If everything goes according to plan, psilocybin therapy could be available publicly in Oregon as soon as 2023. Psilocybin mushrooms are classified as Schedule I drug—the same schedule as cannabis. Like cannabis, there was a time before psychedelics were broadly criminalized and were used primarily for their medicinal properties.

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

SEPTEMBER 22, 2022

Acting in one fell swoop, on September 18, 2022, California Governor Gavin Newsom signed 10 cannabis-related legislative bills into law. Senate Bill 1326 is the most widely recognized bill of the group, and authorizes the Governor the power to sign cannabis trade agreements with other states where cannabis is legal.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

NOVEMBER 4, 2021

The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. Measure 109 requires the Advisory Board to give recommendations to OHA on the efficacy and safety of psilocybin therapy. By Brett Mulligan.

Law 52

Law Therapy Treatment Policy 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Defining Psychedelics. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

SEPTEMBER 10, 2022

The Oregon legislative Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production is exploring potential reforms to the state’s regulation of cannabinoid products and legislation for 2023 to combat what law enforcement believes is an increase in illicit marijuana production. The OLCC argued that H.B.

Seed-To-Sale 52

Seed-To-Sale Hemp Cannabinoids Legislation 52

Cannabis Law Report

JANUARY 9, 2022

Legalizing cannabis for adults has been a wise investment. billion in tax revenue from legal, adult-use cannabis sales. billion in tax revenue from legal, adult-use cannabis sales. This document reviews each state’s adult-use cannabis tax structure, population, and revenue from legalization. Here’s what they say.

Collective 52

Collective Policy Retail Programs 52

The Joint Blog

JANUARY 12, 2020

billion by 2023, according to the cannabis research firm Brightfield Group and noted by the AP. This year, it has sent warning letters to 22 companies citing violations such as making claims about therapeutic uses and treatment of disease in humans or animals or marketing CBD as a dietary supplement or food ingredient.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105

The Joint Blog

JANUARY 28, 2020

billion by 2023, according to the cannabis research firm Brightfield Group.” “This year, it has sent warning letters to 22 companies citing violations such as making claims about therapeutic uses and treatment of disease in humans or animals or marketing CBD as a dietary supplement or food ingredient”, notes the AP.

Pets 26

Pets CBD Research and Development Oil 26

Veriheal

SEPTEMBER 7, 2022

implemented a revolutionary emergency amendment to its medical cannabis program. residents over the age of 21 to self-certify their intent to use cannabis for medical purposes when applying for D.C.’s ’s Medical Cannabis Program. ’s safe and regulated cannabis market, minimize D.C.’s Pushing D.C.’s

Patients 85

Patients Programs Access Treatment 85

The Blunt Truth

DECEMBER 9, 2022

And finally, the cannabis industry is getting into the holiday spirit. Many in the industry thought that the National Defense Authorization Act would be the vehicle that would finally carry cannabis banking to legalization, but that’s not going to happen. In Ohio , organizers are looking to a 2023 election. SAFE BANKING ACT.

Banking 110

Banking Collective Safety Treatment 110

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Veriheal

DECEMBER 22, 2022

On Tuesday, Nov, 15, the governor of Kentucky inked his signature on two cannabis-related executive orders. Andy Beshear (Democratic Party) outlined a list of conditions that state residents must meet to access medicinal-grade cannabis starting on Jan. Patients Could Still Face Legal Action for Medical Cannabis Possession.

THC 62

THC Conditions Policy Packaging 62